|
|
|
|
pmid:
|
|
|
|
|
pmid:3360596
|
|
|
|
|
pmid:9870780
|
Pastores SM et al. |
Posttraumatic multiple-organ dysfunction syndrome: role of mediators in systemic inflammation and subsequent organ failure. |
1996 |
Acad Emerg Med |
pmid:8727633
|
Goldring WP and Pattenden G |
The phomactins. A novel group of terpenoid platelet activating factor antagonists related biogenetically to the taxanes. |
2006 |
Acc. Chem. Res. |
pmid:16700534
|
Yamada T et al. |
Effects of inhaled nitric oxide on platelet-activating factor-induced pulmonary hypertension in dogs. |
1998 |
Acta Anaesthesiol Scand |
pmid:9542566
|
Nathan N et al. |
Variations in blood platelet-activating-factor levels after protamine reversal of heparin in humans. |
1992 |
Acta Anaesthesiol Scand |
pmid:1574976
|
Sipka S et al. |
Atropine is an inhibitor of the chemiluminescence induced by platelet-activating factor in human neutrophils. |
1987 |
Acta Biochim. Biophys. Hung. |
pmid:3132002
|
Ren J et al. |
Protective effect of dexmedetomidine against myocardial ischemia-reperfusion injury in rabbits. |
2018 |
Acta Cir Bras |
pmid:29412230
|
Peterson JR et al. |
Platelet activating factor antagonist design. 3. X-ray crystal structure and intermolecular crystal lattice interactions of methyl trans-4-acetoxymethyl-4,5-dihydro-2,5-bis(3,4-methylenedioxyphenyl)- 3-furancarboxylate. |
1989 |
Acta Crystallogr C |
pmid:2604943
|
Peterson JR et al. |
Platelet activating factor antagonist design: structure of methyl trans-5-(3,4-dimethoxyphenyl)-2,3,4,5-tetrahydro-2-oxo-4- furancarboxylate. |
1989 |
Acta Crystallogr C |
pmid:2610971
|
Peterson JR et al. |
Platelet activating factor antagonist design. 2. X-ray structure of dimethyl 2,3,4,5-tetrahydro-5 beta-(3,4-methylenedioxyphenyl)-2-oxo-3 beta-(3,4,5-trimethoxybenzoyl)-3 alpha,4 alpha-furandicarboxylate. |
1989 |
Acta Crystallogr C |
pmid:2610989
|
Stensland JB et al. |
Platelet activating factor antagonists. Structure of N,N'-bis(3,4,5-trimethoxybenzoyl)-2-piperazinylmethyl 2,2-dimethylpropanoate. |
1991 |
Acta Crystallogr C |
pmid:1930821
|
Juhlin L and Pihl-Lundin I |
Effects of antihistamines on cutaneous reactions and influx of eosinophils after local injection of PAF, kallikrein, compound 48/80 and histamine in patients with chronic urticaria and healthy subjects. |
1992 |
Acta Derm. Venereol. |
pmid:1357858
|
Juhlin L and Rihoux JP |
Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria. |
1990 |
Acta Derm. Venereol. |
pmid:1969202
|
Fjellner B and Hägermark O |
Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. |
1985 |
Acta Derm. Venereol. |
pmid:2416164
|
Abramovici Y et al. |
Control of the proliferation and differentiation of GEJ under platelet aggregating factor treatment. |
1987 |
Acta Endocrinol Suppl (Copenh) |
pmid:3475908
|
Plachot M |
Markers for establishing the adequacy of embryonal development in assisted conception. |
1993 Sep-Oct |
Acta Eur. Fertil. |
pmid:7985464
|
Aderka D et al. |
Morphological platelet anomalies in thrombotic thrombocytopenic purpura. |
1982 |
Acta Haematol. |
pmid:6801893
|
Bussolino F et al. |
Platelet-activating factor--a powerful lipid autacoid possibly involved in microangiopathy. |
1986 |
Acta Haematol. |
pmid:3019063
|
Akisü M et al. |
The effect of L-carnitine on platelet activating factor concentration in the immature rat model of hypoxic-ischemic brain injury. |
1998 |
Acta Med. Okayama |
pmid:9781268
|
Hashimoto K et al. |
Comparison of the effects of intra-third ventricular administration of interleukin-1 or platelet activating factor on ACTH secretion and the sympathetic-adrenomedullary system in conscious rats. |
1993 |
Acta Med. Okayama |
pmid:8384777
|
Vargaftig BB et al. |
One, two, three or more pathways for platelet aggregation. |
1980 |
Acta Med. Scand. Suppl. |
pmid:6779505
|
Hirasima Y et al. |
Platelet-activating factor (PAF) and the development of chronic subdural haematoma. |
1994 |
Acta Neurochir (Wien) |
pmid:7998491
|
Hirashima Y et al. |
Platelet-activating factor (PAF) and the formation of chronic subdural haematoma. Measurement of plasma PAF levels and anti-PAF immunoglobulin titers. |
1995 |
Acta Neurochir (Wien) |
pmid:8748861
|
Hirashima Y et al. |
Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage. |
1994 |
Acta Neurochir (Wien) |
pmid:7847132
|
Hallenbeck JM |
Blood-damaged tissue interaction in experimental brain ischemia. |
1994 |
Acta Neurochir Suppl (Wien) |
pmid:7976554
|
Tokutomi T et al. |
Effect of platelet-activating factor antagonist on brain injury in rats. |
1994 |
Acta Neurochir Suppl (Wien) |
pmid:7976632
|
Maeda T et al. |
Hemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor. |
1997 |
Acta Neurochir. Suppl. |
pmid:9416292
|
Khan SN et al. |
Response to platelet-activating factor of platelets from patients with multiple sclerosis. |
1985 |
Acta Neurol. Scand. |
pmid:3993327
|
Satoh K et al. |
Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke. |
1992 |
Acta Neurol. Scand. |
pmid:1574985
|
Doly M et al. |
Protective effect of a specific PAF antagonist on vincristine-induced experimental retinopathy. |
1995 |
Acta Ophthalmol Scand |
pmid:7656145
|
Pettorossi VE and Grassi S |
Different contributions of platelet-activating factor and nitric oxide in long-term potentiation of the rat medial vestibular nuclei. |
2001 |
Acta Otolaryngol Suppl |
pmid:11677732
|
Nakano T et al. |
Roxythromycin reinforces epithelial defence function in rabbit trachea. |
1998 |
Acta Otolaryngol Suppl |
pmid:9879427
|
Minami T et al. |
Regional blood flow volume in the eustachian tube. |
1993 |
Acta Otolaryngol Suppl |
pmid:8452027
|
Lin J et al. |
Effects of platelet-activating factor (PAF) receptor blockage on mucous glycoprotein secretion in cultured chinchilla middle ear epithelium. |
1996 |
Acta Otolaryngol. |
pmid:8820353
|
Terada N et al. |
The effect of anti-VLA-4 monoclonal antibody on eosinophil accumulation and leukotriene production in nasal mucosa. |
1996 |
Acta Otolaryngol. |
pmid:8973726
|
Ganbo T and Hisamatsu K |
Mucosal dysfunction and damage induced by platelet activating factor (PAF). |
1990 Nov-Dec |
Acta Otolaryngol. |
pmid:2284918
|
Minami T et al. |
Effects of various inflammatory mediators on eustachian tube patency. |
1992 |
Acta Otolaryngol. |
pmid:1442015
|
Dolata J et al. |
The influence of leukotrienes and platelet activating factor on mucociliary activity in the rabbit maxillary sinus. |
1990 Jan-Feb |
Acta Otolaryngol. |
pmid:2309553
|
Furukawa M et al. |
Presence of platelet-activating factor in nasal polyps and eosinophils. |
2002 |
Acta Otolaryngol. |
pmid:12542208
|
Lin J et al. |
Dexamethasone inhibits mucous glycoprotein secretion via a phospholipase A2-dependent mechanism in cultured chinchilla middle ear epithelial cells. |
1997 |
Acta Otolaryngol. |
pmid:9199527
|
Bellioni P et al. |
[Histomorphological changes in nasal polyps in patients with glucose metabolism disorders]. |
1988 Nov-Dec |
Acta Otorhinolaryngol Ital |
pmid:3247845
|
Akisü M et al. |
Plasma platelet-activating factor levels in newborn infants with and without perinatal asphyxia: is it an additional marker of perinatal asphyxia? |
1998 |
Acta Paediatr Jpn |
pmid:9821700
|
Hüseyinov A et al. |
Plasma and urinary platelet activating factor concentrations and leukotriene releasing activity of leukocytes in steroid sensitive nephrotic syndrome of childhood. |
1998 |
Acta Paediatr Jpn |
pmid:9583202
|
Nagakura T et al. |
Chemical mediators in hypersensitivity reactions. |
1990 |
Acta Paediatr Jpn |
pmid:1974103
|
Ewer AK |
Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis. |
2002 |
Acta Paediatr Suppl |
pmid:12200892
|
Hsueh W et al. |
Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis. |
1994 |
Acta Paediatr Suppl |
pmid:8086673
|
Dahlbäck M et al. |
Bronchial anaphylaxis in actively sensitized Sprague Dawley rats: studies on mediators involved. |
1984 |
Acta Pharmacol Toxicol (Copenh) |
pmid:6431753
|
Saeed SA and Rasheed H |
Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation. |
2003 |
Acta Pharmacol. Sin. |
pmid:12511226
|